Hygeia Pharmaceuticals
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad pharmaceutical manufacturer operating since 2003 with GMP-oriented production and multiple registered pharmaceutical products.
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- Plot No. 295, Industrial Triangle, Kahuta Road, Islamabad, Pakistan
- Website
- hygeiapharma.com ↗
- Phone
- +92 51 4490882; +92 51 4490983
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Hygeia Pharmaceuticals is priced against the market
2 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Algac TabletRegistry verified | Loratadine ...... 10 mg | — | Tablet | — | 031811Official source ↗ | No indexed price | — | — |
| Allergid TabletRegistry verified | Citirizine 2HCL ...... 10 mg | — | Tablet | — | 031810Official source ↗ | No indexed price | — | — |
| Amlotac 5mg TabletRegistry verified | Amlodipine (as besylate) ...... 5 mg | — | Tablet | — | 031827Official source ↗ | No indexed price | — | — |
| Amlotac-10 TabletRegistry verified | Amlodipine (as besylate) ...... 10 mg | — | Tablet | — | 031828Official source ↗ | No indexed price | — | — |
| Anzole 500mg InfusionRegistry verified | Metronidazole ...... 500mg % | — | Infusion | — | 072791Official source ↗ | No indexed price | — | — |
| Azitek 200mg Dry SuspensionRegistry verified | — | — | Suspension | — | 072786Official source ↗ | No indexed price | — | — |
| Azitek Capsule 250mgRegistry verified | Azithromycin (as dihydrate) ...... 250 mgAzithromycin ...... 250 mg | — | Capsule | — | 034429Official source ↗ | No indexed price | — | — |
| Azitek TabletRegistry verified | Azithromycin (as dihydrate) ...... 250 mg | — | Tablet | — | 031816Official source ↗ | No indexed price | — | — |
| Bekolol 50mg TabletRegistry verified | Atenolol ...... 50 mg | — | Tablet | — | 031829Official source ↗ | No indexed price | — | — |
| Bekolol-100 TabletsRegistry verified | Atenolol ...... 100 mg | — | Tablet | — | 031830Official source ↗ | No indexed price | — | — |
| Cardaktin 50mg TabletRegistry verified | Losartan Potassium ...... 50 mg | — | Tablet | — | 031832Official source ↗ | No indexed price | — | — |
| Caveat Dry Suspension 125mg/5mlRegistry verified | Cefaclor ...... 125 mg | — | Suspension | — | 034434Official source ↗ | No indexed price | — | — |
| Caveat Dry Suspension 250mg/5mlRegistry verified | Cefaclor ...... 250 mg | — | Suspension | — | 034435Official source ↗ | No indexed price | — | — |
| Cepasafe 250mg CapsuleRegistry verified | — | — | Capsule | — | 072782Official source ↗ | No indexed price | — | — |
| Cepasafe 500mg CapsuleRegistry verified | — | — | Capsule | — | 072783Official source ↗ | No indexed price | — | — |
| Cepsafe Dry Suspension 125mg/5mlRegistry verified | Cephradine ...... 125 mg | — | Suspension | — | 034432Official source ↗ | No indexed price | — | — |
| Cepsafe Suspension 250mgRegistry verified | Cephradine ...... 250 mg | — | Suspension | — | 034433Official source ↗ | No indexed price | — | — |
| Ciprocure 125mg Dry SuspensionRegistry verified | Ciprofloxacin ...... 125 mg | — | Suspension | — | 072787Official source ↗ | No indexed price | — | — |
| Ciprocure 200mg InfusionRegistry verified | Ciprofloxacin as Lactate ...... 200mg/100ml mg/ml | — | Infusion | — | 072792Official source ↗ | No indexed price | — | — |
| Ciprocure 250mg Dry SuspensionRegistry verified | Ciprofloxacin ...... 250mg/5ml mg | — | Suspension | — | 072788Official source ↗ | No indexed price | — | — |
| Ciprocure 250mg TabletRegistry verified | Ciprofloxacin as HCl ...... 250 mg | — | Tablet | — | 031788Official source ↗ | No indexed price | — | — |
| Ciprocure 500mg TabletRegistry verified | Ciprofloxacin (as HCl) ...... 500 mg | — | Tablet | — | 031789Official source ↗ | No indexed price | — | — |
| Clarilide 125mg Dry SuspensionRegistry verified | Clarithromycin ...... 125mg/5ml mg | — | Suspension | — | 072789Official source ↗ | No indexed price | — | — |
| Clarilide 250mg TabletRegistry verified | Clarithromycin ...... 250 mg | — | Tablet | — | 031812Official source ↗ | No indexed price | — | — |
| Clokleen-100 TabletsRegistry verified | Clotrimazole ...... 100 mg | — | Tablet | — | 034438Official source ↗ | No indexed price | — | — |
| Cloxleen Tablet 500mgRegistry verified | Clotrimazole ...... 500 mg | — | Tablet | — | 034439Official source ↗ | No indexed price | — | — |
| Emphatic 200mg TabletRegistry verified | Celecoxib ...... 200 mg | — | Tablet | — | 034445Official source ↗ | No indexed price | — | — |
| Hydin | Povidone-iodine | 7.5 % | Solution | 450ml | 135699 | PKR 740.00 | PKR 1.64/mL | 🔒 Pharma Pro |
| Hydin | Povidone-iodine | 10 % | Solution | 450ml | 135700 | PKR 718.00 | PKR 1.60/mL | 🔒 Pharma Pro |
| Proprazole 40 mg IV InjectionRegistry verified | Omeprazole as sodium | — | — | — | 119675Official source ↗ | No indexed price | — | — |
| Tenorox 150mg TabletRegistry verified | Clarithromycin ...... 500 mg | — | Tablet | — | 031813Official source ↗ | No indexed price | — | — |
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.